CTLA4 and neoplasm: In the B16 model, RFA and cryoablation have also been combined with a checkpoint blockade antibody directed against CTLA-4, resulting in increased numbers of tumor-specific T cells with increased IFN-γ secretion potential, and protection against outgrowth of tumor rechallenges [25].